Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

51.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
51.8K
Allergic Reactions02:06

Allergic Reactions

26.4K
Overview
26.4K
Adherens Junctions01:24

Adherens Junctions

5.8K
Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types –  adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as  epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as  heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
5.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.

Chronic respiratory disease·2017
Same author

Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Allergic Fungal Airway Disease.

Journal of investigational allergology & clinical immunology·2016
Same author

The relationship between biomarkers of fungal allergy and lung damage in asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma.

Allergy·2016
Same author

Autophagy and Asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same journal

Corrigendum.

The Journal of allergy and clinical immunology·2026
Same journal

Comparative Efficacy of Biologic Agents for Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Network Meta-analysis.

The Journal of allergy and clinical immunology·2026
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.0K

Eosinophil adhesion in allergic inflammation

A J Wardlaw1, F S Symon, G M Walsh

  • 1Department of Respiratory Medicine, Leicester University School of Medicine, Glenfield Hospital, UK.

The Journal of Allergy and Clinical Immunology
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Eosinophil adhesion, similar to basophils, differs from neutrophils. These differences, including VLA-4 and alpha 4/beta 7 expression, may offer new treatments for eosinophil-mediated diseases.

More Related Videos

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

5.7K
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.6K

Related Experiment Videos

Last Updated: May 3, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.0K
Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
08:44

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation

Published on: May 30, 2020

5.7K
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

1.6K

Area of Science:

  • Immunology
  • Cell Biology
  • Allergy Research

Background:

  • Eosinophil adhesion mechanisms are increasingly understood.
  • Eosinophil adhesion patterns resemble basophils more than neutrophils.
  • Differences in eosinophil adhesion present therapeutic opportunities.

Purpose of the Study:

  • To review recent findings on eosinophil adhesion.
  • To highlight key differences between eosinophil and neutrophil adhesion.
  • To explore the therapeutic potential of these differences in eosinophil-mediated diseases.

Main Methods:

  • Review of existing literature on eosinophil adhesion.
  • Comparative analysis of eosinophil, basophil, and neutrophil adhesion interactions.
  • Examination of cytokine modulation (e.g., IL-5) and receptor expression (e.g., VLA-4, alpha 4/beta 7).

Main Results:

  • Eosinophils share adhesion similarities with basophils, distinct from neutrophils.
  • Eosinophil adhesion is modulated by cytokines like IL-5.
  • Eosinophils express VLA-4 and alpha 4/beta 7, unlike neutrophils.
  • Differential interactions with selectins and varying binding affinities observed in eosinophils.

Conclusions:

  • Eosinophil adhesion characteristics offer potential therapeutic targets for allergic diseases.
  • Targeting specific adhesion molecules like VLA-4 could be beneficial.
  • Further research is needed to fully translate these findings into clinical treatments.